Advanced Targeted Therapeutic Strategies for Glioblastoma Multiforme: Bevacizumab and Its Emerging Nanotechnology-Based Interventions
Bevacizumab is an important treatment for glioblastoma multiforme (GBM), especially after surgery, radiation, and chemotherapy, but it has not yet been successfully used to treat recurrent or progressive tumors. Bevacizumab is a humanized monoclonal antibody that targets vascular endothelial growth...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Istanbul University Press
2024-12-01
|
| Edice: | Experimed |
| Témata: | |
| On-line přístup: | https://dergipark.org.tr/en/download/article-file/4316959 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|